Physician profile
Julio E Schwarz
NPI 1295997302
$5,054.57
in general payments reported to CMS, 2019-2025
38 companies · $814 in 2025
The $814 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $1,008 · 2021: $511 · 2022: $951 · 2023: $360 · 2024: $796 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,969.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $867.53 | 2019-2022 | |
| Abbott Laboratories | $468.01 | 2020-2025 | Assurity, Merlin@Home, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $328.21 | 2019-2025 | Lifevest |
| Amgen INC. | $317.40 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $297.35 | 2019-2024 | Andexxa |
| Boston Scientific Corporation | $246.08 | 2019-2024 | Watchman Flx, Peripheral Rotalink Plus, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $234.92 | 2022-2025 | Eliquis, Camzyos |
| Atricure, INC. | $223.38 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $223.29 | 2019-2025 | |
| Edwards Lifesciences Corporation | $217.37 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $168.93 | 2020-2025 | Impella |
| Merck Sharp & Dohme LLC | $165.59 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.65 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $132.73 | 2019-2025 | Opsumit |
| Novo Nordisk INC | $125.70 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $93.44 | 2019-2021 | |
| Shockwave Medical, INC | $88.72 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $78.56 | 2020-2022 | |
| Philips North America LLC | $67.16 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Angiodynamics, INC. | $56.20 | 2025 | Auryon Laser System 100-120 Vac |
| Becton, Dickinson and Company | $54.47 | 2024 | Lutonix Drug Coated Balloon |
| Inari Medical, INC. | $53.90 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $50.51 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $43.79 | 2019-2025 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $35.53 | 2024 | Arcalyst |
| Medtronic, INC. | $32.30 | 2021-2022 | |
| Pfizer INC. | $30.11 | 2024 | |
| Stryker Corporation | $29.12 | 2025 | Flowtriever |
| Bard Peripheral Vascular, INC. | $28.97 | 2024 | Lutonix Drug Coated Balloon |
| Vital Connect, INC | $27.93 | 2025 | Vitalpatch Rtm |
| Alnylam Pharmaceuticals INC. | $20.74 | 2025 | Amvuttra |
| Cvrx, INC. | $19.71 | 2023 | Barostim Neo System |
| Medicomp INC | $17.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.45 | 2025 | |
| Daiichi Sankyo INC. | $17.13 | 2023 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $14.49 | 2020 | |
| Terumo Medical Corporation | $13.39 | 2023 | Angio-Seal, Glidewire |
| Vivaquant INC, Dba Rhythm Express | $6.20 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Schwarz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.